IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
List of Products
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
Margin Calculator
RESEARCH
MARKETS
Overview
Equity
Derivatives
IPO
Mutual Funds
Commodity
Currency
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
List of Products
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
MARGIN CALCULATOR
RESEARCH
MARKETS
OVERVIEW
EQUITY
DERIVATIVES
IPO
MUTUAL FUND
COMMODITY
CURRENCY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Derivatives
Currency
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Derivative
Currency
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Aarti Drugs Ltd
BSE Code
524348
ISIN Demat
INE767A01016
Book Value (₹)
126.18
NSE Symbol
AARTIDRUGS
Div & Yield %
0.29
Market Cap (
₹
Cr.)
3,206.23
P/E *
24.3
EPS *
14.35
Face Value (₹)
10
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
347.70
Change
-2.60 (-0.74%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
345.45 - 361.35
52-Week Range
312.50 - 634.90
Beta (1 Year)
0.71
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Aarti Drugs to convene board meeting
Aarti Drugs Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Aarti Drugs Ltd - Disclosure Under Regulation 30 Of SEBI Listing Regulations
Aarti Drugs Ltd - Closure of Trading Window
Aarti Drugs Ltd - Aarti Drugs Limited - Other General Purpose
Aarti Drugs Ltd - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ('Listing Re...
Aarti Drugs Ltd - Aarti Drugs Limited - Updates
Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Aarti Drugs Ltd - Disclosure Under Reg 30 Of Listing Regulations - Update On Lifting Of Import Alert 66-40 By US DFA
Aarti Drugs Ltd - Disclosure Under Regulation 30 Of Listing Reguations- Order Of CGST And C.Ex. Authority
Corporate Details
Incorporation Year :
1984
Chairman :
C V Gogri
Ownership Group :
Alchemie Group
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs
Registered Office :
Aarti Drugs Ltd
Plot No N-198 MIDC Tarapur,
Pamtembhi Village Palghar Tal,
Thane,
Maharashtra - 401506,
Phone : 91-22-24072249,
Fax : 91-22-24073462/24070144
E-Mail :
investorrelations@aartidrugs.com
URL :
http://www.aartidrugs.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
23-Apr-2025
365.00
-4.45
1Month
01-Apr-2025
343.30
1.59
3Month
30-Jan-2025
407.65
-14.45
6Month
30-Oct-2024
485.05
-28.10
1Year
30-Apr-2024
504.55
-30.88
Mutual Funds Holding
Scheme Name
% Holding
Market Value
No Data Found
Peerset : Pharmaceuticals - Indian - Bulk Drugs
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Divis Laboratories Ltd
6,086.15
-0.42
6,448.75
3,725.55
161,568.16
Neuland Laboratories Ltd
12,036.90
-1.92
18,089.55
5,557.00
15,443.21
Jubilant Pharmova Ltd
897.30
0.11
1,309.00
616.85
14,293.99
Ami Organics Ltd
1,130.50
3.76
1,321.75
507.23
9,255.28
Dishman Pharmaceuticals and Chemicals Ltd(Merged)
301.05
0.00
0.00
0.00
4,858.77
Index Details
BSE HC, BSE SmallCap